| Titre : | Necrotizing pneumonia in children: Report of 25 cases between 2008 and 2018 at a French tertiary care center (2024) |
| Auteurs : | Manon Cathalau, Auteur ; Marine Michelet, Auteur ; Aurélien Rancé, Auteur ; Guillaume Martin-Blondel, Auteur ; Olivier Abbo, Auteur ; Damien Dubois, Auteur ; Géraldine Labouret, Auteur ; Erick Grouteau, Auteur ; Isabelle Claudet, Auteur ; Lucas Ricco, Auteur ; Léa Roditis, Auteur ; Jean-Michel Mansuy, Auteur ; Sophie Simon, Auteur ; Camille Bréhin, Auteur |
| Type de document : | Article |
| Dans : | Archives de pédiatrie (Vol. 31, n°3, avril 2024) |
| Article en page(s) : | 183-187 |
| Langues: | Français |
| Catégories : | |
| Résumé : |
Background: Necrotizing pneumonia (NP) is a serious and rare disease in children. Pediatric data on NP are limited and the impact of the 13-valent pneumococcal conjugate vaccine has been very poorly evaluated.
Patients and methods: We conducted a retrospective study at Toulouse University Hospital between 2008 and 2018. Children who presented with thin-walled cavities in the areas of parenchymal consolidation on imaging were included in the study. Results: The incidence of NP did not decrease during this period. Bacterial identification occurred in 56% of cases (14/25) and included six cases of Streptococcus pneumoniae, five of Staphylococcus aureus, two of Streptococcus pyogenes, and one of Streptococcus viridans. Streptococcus pneumoniae NP are more frequently associated with empyema/parapneumonic effusion compared to S. aureus NP (p = 0.02). Patients with S. pyogenes NP more often required volume expansion than did S. pneumoniae cases (p = 0.03). When comparing children born before and after implementation of the 13-valent pneumococcal conjugate vaccine, we identified a relative modification of the bacterial epidemiology, with an increase in the proportion of S. pyogenes NP and S. aureus NP and a decrease in the proportion of NP caused by S. pneumoniae. Conclusion: Future studies are needed to assess the epidemiology of NP in children. Continued surveillance of identified pneumococcal serotypes is essential to document epidemiological changes in the coming years. (RA) |
Exemplaires (1)
| Code-barres | Cote | Support | Localisation | Section | Disponibilité | lien web |
|---|---|---|---|---|---|---|
| ESF03955 | PER | Périodique | Bibliothèque ESF | Périodique | Disponible |
